Ubs Group Ag Eli Lilly & CO Put Options Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $73.2 Million - $91 Million	94,800 Added 51.38%	279,300 $247 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $19.4 Million - $24.3 Million	-26,700 Reduced 12.64%	184,500 $167 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $32.1 Million - $42.9 Million	-54,182 Reduced 20.42%	211,200 $164 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $82.5 Million - $97.3 Million	157,113 Added 145.11%	265,382 $155 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $22.4 Million - $30.9 Million	51,569 Added 90.95%	108,269 $58.2 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $1.58 Million - $2.11 Million	4,500 Added 8.62%	56,700 $26.6 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $5 Million - $5.88 Million	-16,107 Reduced 23.58%	52,200 $17.9 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $12 Million - $14 Million	37,307 Added 120.35%	68,307 $25 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $1.48 Million - $1.69 Million	5,000 Added 19.23%	31,000 $10 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $2.34 Million - $2.75 Million	-8,400 Reduced 24.42%	26,000 $8.43 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $29.9 Million - $37.2 Million	-127,496 Reduced 78.75%	34,400 $9.85 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $10.7 Million - $13.3 Million	-47,568 Reduced 22.71%	161,896 $44.7 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $4.08 Million - $5.02 Million	18,400 Added 9.63%	209,464 $48.4 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $4.51 Million - $5.84 Million	-25,000 Reduced 11.57%	191,064 $43.9 Million
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $1.28 Million - $1.65 Million	7,764 Added 3.73%	216,064 $40.4 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $18.7 Million - $24.7 Million	143,300 Added 220.46%	208,300 $35.2 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $5.85 Million - $6.77 Million	40,000 Added 160.0%	65,000 $9.62 Million
Q2 2020 Jul 31, 2020	SELL	$136.42 - $164.18 $10.1 Million - $12.2 Million	-74,100 Reduced 74.77%	25,000 $4.11 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $53,460 - $66,215	500 Added 0.51%	99,100 $13 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $6.55 Million - $7.12 Million	-61,300 Reduced 38.34%	98,600 $11 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $8.76 Million - $10.2 Million	-79,100 Reduced 33.1%	159,900 $17.7 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $7.07 Million - $8.32 Million	-63,500 Reduced 20.99%	239,000 $31 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $11.1 Million - $12.4 Million	-104,900 Reduced 25.75%	302,500 $35 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $12.9 Million - $16.1 Million	150,000 Added 58.28%	407,400 $43.7 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $37,850 - $43,440	-500 Reduced 0.19%	257,400 $22 Million
Q1 2018 May 15, 2018	BUY	$74.21 - $87.6 $19.1 Million - $22.5 Million	257,400 Added 51480.0%	257,900 $20 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $229,432 - $246,092	-2,800 Reduced 84.85%	500 $42,000
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $6.17 Million - $6.84 Million	-80,000 Reduced 96.04%	3,300 $282,000
Q1 2017 Nov 14, 2017	BUY	N/A	83,300	83,300 $7.01 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account